2.1.1.2.2.1.2.1.2.2. Eyelid design for detection, including (a) water suspension of acute formic acid A particles, (b) surfactant and (c) preservative； preparation process； and methods of reducing intraocular pressure including the application of this formulation.
Provided herein is an ophthalmic formulation that comprises a fine particle of an A1 agonist in an aqueous suspension and a manufacturing process thereof. More specifically, provided herein is a topically applied ophthalmic aqueous suspension which is obtainable by suspending a fine particle of an A1 agonist in a surfactant and preservative； a method of reduction of intraocular pressure using the formulation and a manufacturing process of the aqueous suspension thereof.FORMULACION OFTALMICA PARA APLICAR TOPICA QUE COMPRENDE A) UNA SUSPENSION ACUOSA DE UNA PARTICULA FINA DE UN AGONISTA A1, B) UN AGENTE TENSIOACTIVO Y C) UN CONSERVANTE； PROCESO PARA PREPARARLA； Y UN METODO PARA REDUCIR LA PRESION INTRAOCULAR QUE COMPRENDE APLICAR DICHA FORMULACION.
